Tuesday, July 24, 2012

Charles Phillips: Infor sets the standard in business intelligence

Charles Phillips Image Credit: lawson.com

Charles Phillips’ Infor is recognized as one of the leaders in business intelligence applications in several sectors, prominently in healthcare. Its Lawson Healthcare suite is trusted by a large number of hospitals in North America, featuring advanced solutions related to analytics, visibility, and other forms of business-significant information. Recently, it has pushed the envelope with the Business Intelligence (BI) add-on module for its Lawson Healthcare Revenue Management, an enhancement set to establish a new grade in business intelligence solutions.

Charles Phillips Image Credit: lawson.com

The role of business intelligence in modern enterprises cannot be understated. In a corporate world rife with competition, and set precariously in a web of volatile factors such as the economy, business intelligence can prevent failure or prepare an entity for any incoming blow. Charles Phillips and Infor continue to uphold their goal of providing the necessary tools and applications that can help today’s enterprises gain an edge over loss and competition—the BI add-on module being their latest offering.

Charles Phillips Image Credit: tnlug.org

The said module is set to add new functions to Lawson Healthcare that will enhance its users’ experience and maximize the value of their software investment. The BI add-on module extends the analytic and reporting capabilities of the Lawson Healthcare Revenue Management suite, and simplifies complex revenue and billing data access using popular tools like Microsoft Excel and Internet Explorer. This allows business analysts to create queries faster and without requiring IT assistance. Additionally, the module uses analytic cubes to store business rules in order to simplify common requests. It also separates reporting requests from the production system to reduce impact on processing and data entry.

Get more updates on Charles Phillips and Infor by visiting this Twitter page.

No comments:

Post a Comment